Primary study · included by 1 review

Langerhans' Cell Histiocytosis in the Paediatric Population: Presentation and Treatment of Head and Neck Manifestationsy

Cochrane 2003 · Cochrane Lesley-Ann, Prince Mark, Clarke Kevin · The Journal of Otolaryngology · 2003

Included by

Prevalence of oral lesions in Langerhans cell histiocytosis: a systematic review and meta-analysis.

Non-Cochrane · prognostic · 2026 · cited as Cochrane 2003 · Table 4; Reference list

Outcome this study informs	Pooled effect	Evidence	Certainty
Prevalence of oral manifestations (oral mucosa or jaw bone lesions) Oral manifestations of LCH (oral mucosa and jaw bone lesions) vs Not applicable (single-arm prevalence) · At diagnosis (not specified)	Proportion 0.097 [0.076, 0.119]	11 studies · 1806 participants	GRADE not reported
Prevalence of oral manifestations (oral mucosa or jaw bone lesions) Oral manifestations of LCH (oral mucosa and jaw bone lesions) vs Not applicable (single-arm prevalence) · At diagnosis (not specified)	Proportion 0.205 [0.144, 0.267]	16 studies · 2052 participants	Low
Prevalence of oral manifestations Oral manifestations (oral mucosa and jaw bone lesions) vs Not applicable · At diagnosis	Prevalence (%) 14.86 [11.80, 18.58]	16 studies · 2052 participants	Low
Prevalence of oral manifestations (oral mucosa or jaw bone lesions) Oral manifestations of LCH (oral mucosa and jaw bone lesions) vs Not applicable (single-arm prevalence) · At diagnosis (not specified)	Proportion 0.1057	11 studies · 1806 participants	GRADE not reported

1 including review in total.